International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1061-1065 , 15 March 2010

Postoperative Nomogram Predicting the 9-Year Probability of Prostate Cancer Recurrence After Permanent Prostate Brachytherapy Using Radiation Dose as a Prognostic Variable

Presented orally at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, October 28–November 1, 2007, Los Angles, CA.

  • Louis Potters, M.D.

      Affiliations

    • Department of Radiation Medicine, North Shore Long Island Jewish Health System, New Hyde Park, NY
    • Corresponding Author InformationReprint requests to: Louis Potters, M.D., Department of Radiation Oncology, North Shore Long Island Jewish Health System, Long Island Jewish Medical Center, 270-05 76th Ave., New Hyde Park, NY 11040. Tel: (718) 470-7190; Fax: (718) 470-0045
    • ,
  • Mack Roach III, M.D.

      Affiliations

    • Departments of Radiation Oncology and Urology, University of California at San Francisco, San Francisco, CA
    • ,
  • Brian J. Davis, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN
    • ,
  • Richard G. Stock, M.D.

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Jay P. Ciezki, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH
    • ,
  • Michael J. Zelefsky, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Nelson N. Stone, M.D.

      Affiliations

    • Department of Urology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Paul A. Fearn, B.A.

      Affiliations

    • Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Changhong Yu, M.S.

      Affiliations

    • Glickman Urological Institute and the Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
    • ,
  • Katsuto Shinohara, M.D.

      Affiliations

    • Departments of Radiation Oncology and Urology, University of California at San Francisco, San Francisco, CA
    • ,
  • Michael W. Kattan, Ph.D.

      Affiliations

    • Glickman Urological Institute and the Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

Received 16 December 2008 ,Revised 14 February 2009 ,Accepted 9 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: R.S. acts as a consultant for Bard. B.D. acts as a consultant for Oncura Inc. and Calypso Inc. and has a financial interest in Tomotherapy Inc. N.S. is a co-owner of Prologics, LLC. No other conflicts.

PII: S0360-3016(09)00469-6

doi: 10.1016/j.ijrobp.2009.03.031

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 1061-1065 , 15 March 2010

Article Tools

* Image Usage & Resolution